We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CRH:NYSECRH PLC analysis

Data as of Oct 21, 2026 - not real-time

Latest price
$85.22
Risk: medium
6/10Medium risk

Summary

CRH plc is priced at $85.22 and its moving averages line up in bearish order, the shorter trailing the longer. The last 30 days have lost 5.9%. With RSI at 51.9 the momentum picture is neutral, alongside a bullish MACD signal. The recent range runs from support at $78.62 up to resistance at $87.00.
Valuation screens as undervalued, on a P/E of 15.1 with no clean sector comparison available. Sell-side targets cluster 46.4% above the current quote. Revenue is growing at 5.6% on a 9.9% profit margin. The 1.83% dividend yield looks covered by current payout levels.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 24.9%, a beta of 1.32 and a maximum drawdown of 39.7%, position sizing matters here. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
The horizons diverge: hold near-term but buy on a long view, at 4/10 conviction over the longer horizon.

Top market events

  • Revenue reached USD 10.78 billion in the second quarter of 2026, up 5.60 percent. CRH stock costs EU
  • Second-quarter revenue rose 5.60 percent to USD 10.78 billion. CRH stock costs EUR 70.89 on October
  • Revenue rose to USD 10.78 billion from USD 10.21 billion in the second quarter. CRH stock trades at

Market outlook

Short term

< 1 year

Neutral

Model confidence1/101 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 105.70
  • MACD momentum is positive

Medium term

1–3 years

Neutral

Model confidence2/102 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 105.70
  • Analyst targets imply +46.4% versus the current price

Long term

> 3 years

Positive

Model confidence4/104 out of 10

Key factors

  • Analyst targets imply +46.4% versus the current price
  • P/E ratio of 15.1
  • Return on equity of 15.8%

Key metrics

Financial health

Revenue Growth5.60%
Profit Margin9.94%
P/E Ratio15.1
ROE15.81%
ROA6.06%
Debt/Equity77.59
P/B Ratio2.4
Op. Cash Flow$5.4B
Free Cash Flow$2.0B

Technical analysis

TrendBearish
RSI51.9
Support$78.62
Resistance$87.00
MA 20$82.74
MA 50$88.67
MA 200$105.70
MACDBullish
VolumeDecreasing
Fear & Greed Index90.75

Valuation

Fair Value$21.09
Target Price$124.79
Upside/Downside46.44%
GradeUndervalued
TypeBlend
Dividend Yield1.83%

Risk assessment

Beta1.32
Volatility24.90%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.